Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2016 Jun 29;12(6):e1006145. doi: 10.1371/journal.pgen.1006145

CDI Systems Are Stably Maintained by a Cell-Contact Mediated Surveillance Mechanism

Zachary C Ruhe 1,*, Josephine Y Nguyen 1, Annette J Chen 1, Nicole Y Leung 1, Christopher S Hayes 1,2, David A Low 1,2
Editor: Diarmaid Hughes3
PMCID: PMC4927057  PMID: 27355474

Abstract

Contact-dependent growth inhibition (CDI) systems are widespread amongst Gram-negative bacteria where they play important roles in inter-cellular competition and biofilm formation. CDI+ bacteria use cell-surface CdiA proteins to bind neighboring bacteria and deliver C-terminal toxin domains. CDI+ cells also express CdiI immunity proteins that specifically neutralize toxins delivered from adjacent siblings. Genomic analyses indicate that cdi loci are commonly found on plasmids and genomic islands, suggesting that these Type 5 secretion systems are spread through horizontal gene transfer. Here, we examine whether CDI toxin and immunity activities serve to stabilize mobile genetic elements using a minimal F plasmid that fails to partition properly during cell division. This F plasmid is lost from Escherichia coli populations within 50 cell generations, but is maintained in ~60% of the cells after 100 generations when the plasmid carries the cdi gene cluster from E. coli strain EC93. By contrast, the ccdAB "plasmid addiction" module normally found on F exerts only a modest stabilizing effect. cdi-dependent plasmid stabilization requires the BamA receptor for CdiA, suggesting that plasmid-free daughter cells are inhibited by siblings that retain the CDI+ plasmid. In support of this model, the CDI+ F plasmid is lost rapidly from cells that carry an additional cdiI immunity gene on a separate plasmid. These results indicate that plasmid stabilization occurs through elimination of non-immune cells arising in the population via plasmid loss. Thus, genetic stabilization reflects a strong selection for immunity to CDI. After long-term passage for more than 300 generations, CDI+ plasmids acquire mutations that increase copy number and result in 100% carriage in the population. Together, these results show that CDI stabilizes genetic elements through a toxin-mediated surveillance mechanism in which cells that lose the CDI system are detected and eliminated by their siblings.

Author Summary

Many bacteria express contact-dependent growth inhibition (CDI) systems, which are used to bind bacteria of the same species together and deliver toxins that block bacterial growth. Sibling cells are protected by a CDI-encoded immunity protein, but unrelated neighbors are inhibited because they lack immunity. Thus, CDI provides a mechanism to identify neighboring cells as "self" or "nonself-". CDI genes are typically found on genomic DNA regions that can move between different bacteria. Here, we find that CDI genes promote the stability of small replicating DNA elements called plasmids, allowing them to be maintained in a population over many generations. If a cell loses the CDI plasmid DNA, then it also loses immunity to toxin and is eliminated by neighboring CDI+ cells. We call this a surveillance mechanism because CDI+ cells continually deliver toxins to test whether their neighbors are true siblings. Cells lacking the CDI genes are recognized as foreign and are eliminated from the population. This work shows that CDI systems exert a powerful selective pressure and act to stabilize DNA elements with which they are associated.

Introduction

Many organisms acquire new genetic information through horizontal gene transfer (HGT), which facilitates rapid adaption to new environments. Bacteria, in particular, use HGT extensively to maintain flexible, fluid genomes that support diverse lifestyles. The genes gained through horizontal transfer allow bacteria to exploit new metabolites, acquire antibiotic resistance, and deploy virulence factors during pathogenesis. Some bacteria are able to take up DNA directly from the environment, but many others acquire mobile genetic elements through conjugation, which requires close contact between donor and recipient cells. Genes are also transferred between cells via bacteriophage-mediated transduction [1]. Because foreign DNAs are potentially deleterious, HGT is often limited by anti-viral defense systems like restriction endonucleases and CRISPR-Cas systems, which recognize and destroy foreign DNAs [2]. Nonetheless, HGT occurs between cells and plays a major role in the evolution of bacteria and other organisms [14]. Once a mobile genetic element gains access to a new cell, it must replicate either as an episome or integrate into the host genome to be passed on to subsequent generations. Plasmids use several strategies to ensure stable maintenance in bacterial hosts. High-copy plasmids exploit the power of numbers, with only a small statistical chance that a cell will be “cured” of plasmid in each generation. Low-copy plasmids carry DNA sequences that function similarly to centromeres, encoding partitioning proteins that actively segregate plasmid DNA into each daughter during cell division [5, 6]. In addition, low-copy plasmids usually express one or more toxin-antitoxin (TA) systems, which stabilize the element through post-segregational killing [79]. TA modules are usually organized as operons with the upstream gene encoding an unstable antitoxin and the downstream gene coding for a stable protein toxin. Type I TA systems use a small RNA to inhibit toxin translation, whereas type II systems produce labile antitoxin proteins that inactivate toxin [10, 11]. Because antitoxin proteins have short half-lives, they must be synthesized continuously to prevent toxin-induced cell death. Thus, daughter cells that fail to receive plasmid can cannot produce antitoxin and eventually succumb to toxin activity. In this manner, TA systems selectively eliminate plasmid-free cells and are sometimes referred to as "plasmid-addiction modules”. This same general mechanism can stabilize chromosomal elements such as prophages and genomic islands [11, 12].

Many Gram-negative bacteria express another class of toxin/antitoxin systems that mediate contact-dependent growth inhibition (CDI) [1317]. In contrast to type II TA systems, CDI toxins are deployed to inhibit the growth of neighboring bacterial cells. CDI is mediated by the CdiB/CdiA family of two-partner secretion proteins. CdiB is an outer-membrane β-barrel protein that exports large, filamentous CdiA effector proteins to the cell surface. CdiA binds specific receptors on susceptible bacteria [18], then delivers its C-terminal toxin domain (CdiA-CT) to inhibit target-cell growth [19, 20]. CDI+ bacteria also exchange toxins with sibling cells, but protect themselves with CdiI immunity proteins, which act as antitoxins to bind CdiA-CT domains and neutralize inhibition activity. CDI systems encode a variety of toxins and immunity proteins, and different strains of the same species commonly possess distinct CdiA-CT/CdiI sequences [14, 21]. Moreover, CDI+ cells can bind to both CDI+ and CDI- cells via CdiA-CdiA and CdiA-receptor interactions, respectively. Because CdiI-mediated immunity is specific for cognate CdiA-CT toxin, toxin/immunity protein polymorphism suggests that CDI functions in inter-strain competition. In this model, strains deploy distinct toxins to compete for growth niches and environmental resources.

The distribution of cdi genes between isolates of a given bacterial species is not necessarily uniform. For example, though every isolate of Neisseria meningitidis, Burkholderia pseudomallei and Yersinia pestis contains at least one cdi gene cluster, only a subset of Escherichia coli strains carry these systems [17, 22]. These observations indicate that cdi genes comprise part of the E. coli accessory genome and are therefore most likely acquired through HGT. Here, we show that E. coli CDI systems are commonly encoded on genomic islands and provide evidence that cdi toxin/immunity coding regions are subject to frequent HGT. Further, we demonstrate that cdi genes from E. coli EC93 can stabilize a horizontally transferred genetic element. CdiAEC93 targets the BamA receptor, delivering a pore-forming CdiA-CTEC93 toxin that reduces the proton motive force in non-immune target cells [23]. We engineered a minimal F plasmid that is rapidly lost from E. coli populations within 50 cell generations. However, this unstable episome is maintained over hundreds of generations when it carries the cdiBAI gene cluster from E. coli EC93. In contrast, the ccdBA TA module normally found on the F plasmid has only a modest effect on stability, with the plasmid being lost by 60 generations. We show that cdi-dependent genetic stabilization requires inter-cellular toxin exchange and reflects the selection for immunity to CDI-mediated growth inhibition. Thus, cdi genes stabilize genetic elements via a surveillance mechanism in which individuals within the population are continually challenged to determine whether they are immune or “self” cells. Individuals that lose the cdi locus are rendered non-immune and are targeted for elimination as “non-self” cells.

Results

E. coli CDI systems are encoded on genomic islands

To examine the genomic context of E. coli cdi gene clusters, we used the cdiA sequence from E. coli EC93 to query the Escherichia taxon using BLAST. The top 961 hit sequences were then analyzed using JContextExplorer to compare cdi gene neighborhoods [24]. This analysis revealed that a large number of E. coli cdi loci are harbored within genomic islands inserted at the 3´-ends of various tRNA genes including leuX, pheV, selC and aspV. The leuX integrated islands are related to the previously characterized pathogenicity island 2 (PAI II536) from uropathogenic E. coli 536 (UPEC 536) (Fig 1A) [25]. In addition to the cdi locus, PAI II536 carries several gene clusters that encode important virulence factors including hemolysin (hly) and fimbriae including Prf and F17 (Fig 1A). Notably, the leuX islands are mosaics and contain distinct complements of genes between different E. coli isolates. For example, the island from E. coli 9.1649 is closely related to PAI II536, but contains an additional F17-like fimbrial operon (Fig 1A). Similarly, the leuX island from E. coli HVH 23 shares most of its genes with PAI II536, but lacks the cluster of choline utilization genes found upstream of the cdi locus (Fig 1A). The island from E. coli HVH 162 retains the choline utilization cluster, but lacks the hemolysin and fimbrial virulence genes found downstream of cdi in other isolates (Fig 1A). This latter difference is also associated with distinct cdi toxin/immunity protein coding sequences in E. coli HVH 162. The CdiA proteins from UPEC 536, E. coli 9.1649 and E. coli HVH 23 all carry the same C-terminal Ntox28 domain (Pfam: PF15605), which has toxic anticodon nuclease activity [14, 26, 27]. CdiA from E. coli HVH 162 carries a non-specific nuclease toxin domain (Pfam: PF13930) [27]. Thus, additional HGT events shape the gene content of each leuX island. The cdi-containing islands integrated at pheV exhibit similar heterogeneity (Fig 1B). There is also greater diversity in cdiA-CT/cdiI coding sequences for these islands. E. coli D9 encodes the same Ntox28 toxin domain as UPEC 536, but CdiA from E. coli FCH1 carries a C-terminal DUF4237 (Pfam: PF14021) domain of unknown function. The CdiA-CT domains from E. coli isolates KTE178 and UMEA 3097 are identical to the toxin from E. coli NC101 [17, 20]. Comparison of the FCH1 and KTE178 islands shows that the cdiA-CT/cdiI sequences from FCH1 have been displaced downstream to form an “orphan” toxin/immunity module (Fig 1B). Such displaced toxin/immunity gene pairs are commonly found downstream of cdiBAI clusters in many different bacterial species [28]. In many instances, orphan toxin/immunity pairs form tandem arrays associated with intervening transposase and integrase genes. Together, these observations suggest that cdi loci are subject to continual modification through transposition and site-specific recombination.

Fig 1. E. coli cdiBAI gene clusters are located on genomic islands.

Fig 1

E. coli genomic islands harboring cdiBAI genes were aligned using the Artemis comparison tool. PAI II islands from 4 different E. coli strains are shown in panel A. Panel B displays 4 genomic islands inserted at pheV in the indicated strains. Homologous CDI DNA sequences are highlighted in blue-violet, homologous non-CDI DNA sequences are shown in light green (direct orientation) and light red (inverted orientation), and genes of interest are shown in orange. Abbreviations: yeeUV, toxin-antitoxin module; choline util, genes involved in choline metabolism; hly, hemolysin biosynthesis; F17, F17 fimbrial genes; prf, P-related fimbriae; lipid biosyn., putative lipid biosynthesis operon; HBA, genes involved in hydroxybenzoate degradation; kps, capsular assembly operon; T1SS, Type I secretion system.

cdi genes stabilize genetic elements

TA modules stabilize plasmids through a phenomenon called post-segregational killing, in which plasmid-free daughter cells are subject to toxin-mediated killing. Because CDI systems also have toxin (CdiA-CT) and antitoxin (CdiI) activities, we asked whether cdi genes have a similar stabilizing effect on genetic elements. Natural genomic islands are stable over long-term passaging [29, 30] and plasmids often harbor several stabilizing elements [31, 32], making it difficult to study the contribution of cdi genes in these contexts. Therefore, we generated an unstable ampicillin-resistant (AmpR) plasmid, pOriF, which uses the F origin to tightly couple plasmid DNA replication to host-cell chromosome replication [33]. Plasmid pOriF does not contain the sopABC locus, which encodes the active partitioning system [34]; nor does it carry the ccdAB TA module that mediates post-segregational killing [35, 36]. Because pOriF lacks elements that normally stabilize F, this episome allows us to study stabilizing effects in isolation through short-term passaging experiments. When propagated in recAhost cells, pOriF was lost from populations after about 50 generations (Fig 2A). Introduction of the ccdAB TA module increased pOriF carriage, but the plasmid was still lost within 60 generations (Fig 2B). Thus, the ccdAB module provides only a modest increase in plasmid stability. We next placed the cdiBAIEC93 genes from E. coli EC93 onto pOriF and monitored the stability of the resulting pCdiBAI plasmid. In the absence of ampicillin selection, pCdiBAI was retained by 40–70% of recAcells over 100 generations (Fig 2C). These results demonstrate that cdi genes are more effective stabilizing elements than previously characterized TA plasmid-addiction modules.

Fig 2. CDI-mediated plasmid stabilization.

Fig 2

E. coli EPI100 populations harboring mini-F plasmid derivatives were passaged daily in broth culture for 100 generations. Randomly selected colonies were screened AmpR after each passage to determine the percentage of cells that retain the plasmid. The average percentage of AmpR colonies is plotted with the standard error indicated by grey shading. A) E. coli EP100 ΔbamA::cat pZS21-BamA pOriF. B) E. coli EP100 ΔbamA::cat pZS21-BamA pCcdAB. C) E. coli EP100 ΔbamA::cat pZS21-BamA pCdiBAI. D) E. coli EP100 ΔbamA::cat pZS21-BamAECL pCdiBAI.

Plasmid stabilization is an emergent property of the CDI mechanism

In principle, cdi genes could stabilize the F episome through an auto-intoxication mechanism similar to TA-mediated plasmid addiction. Alternatively, genetic stability could be enforced through inter-cellular toxin delivery to inhibit plasmid-free cells. To differentiate between these two mechanisms, we examined pCdiBAI stability in E. coli cells that cannot exchange toxins with one another. CdiAEC93 uses the E. coli BamA protein as a cell-surface receptor to bind target bacteria [18], but does not recognize BamA from other bacterial species [37]. Therefore, we introduced pCdiBAI into E. coli bamAECL cells, which express heterologous BamA from Enterobacter cloacae and are completely resistant to CDIEC93 [37]. pCdiBAI was lost from bamAECL populations at the same rate as pOriF (Fig 2, compare panels A and D), suggesting that plasmid stabilization requires cell-to-cell delivery of CDI toxins. Thus, plasmid-free cells are likely eliminated from the population by toxin-deploying siblings that retain pCdiBAI. To test this model, we identified and enumerated CDI-intoxicated cells in populations that harbor pCdiBAI. CdiAEC93 delivers a pore-forming toxin that dissipates the proton-motive force in target bacteria [23]. Because the proton-motive force is required to export ethidium bromide (EtBr) dye, intoxicated bacteria become highly fluorescent when incubated with EtBr [38]. Fluorescence microscopy of populations that carry pCdiBAI revealed that 37% of the cells were stained with EtBr, compared to about 6% of cells in populations with pOriF (Fig 3A and 3B). Moreover, bamAECL populations harboring pCdiBAI showed about the same percentage of fluorescent cells as the pOriF population (Fig 3A and 3B). Thus, a significant proportion of cells in the pCdiBAI population show signs of CDI-mediated intoxication. Collectively, these data suggest that pCdiBAI is maintained in the population because it protects hosts from CDI-mediated cell killing. If this model is correct, then expression of the cdiI immunity gene from a second, unlinked locus should relieve the selective pressure to retain pCdiBAI. Therefore, we monitored F episome stability in cells that express cdiI from a pACYC184 multi-copy vector. The pACYC184 vector itself has no effect on pOriF stability (Fig 4A), nor did the pCdiI expression plasmid (Fig 4B). However, pCdiBAI was lost very rapidly from populations that also harbored pCdiI, similar to the pOriF/pCdiI control (Fig 4B and 4D). Collectively, these results indicate that pCdiBAI stability reflects the selective pressure to retain and express the cdiI immunity gene.

Fig 3. Ethidium bromide uptake analysis.

Fig 3

A) E. coli EPI100 populations carrying the indicated mini-F derivatives were stained with EtBr and visualized by fluorescence microscopy. B) The fraction of EtBr-stained cells was quantified from the populations in panel A and presented as the average ± standard error of the mean.

Fig 4. Plasmid stabilization reflects the selection for immunity to CDI.

Fig 4

E. coli EPI100 populations harboring mini-F plasmid derivatives were passaged daily in broth culture for 100 generations. Randomly selected colonies were screened AmpR after each passage to determine the percentage of cells that retain the plasmid. The average percentage of AmpR colonies is plotted with the standard error indicated by grey shading. A) E. coli EP100 pOriF pACYC184. B) E. coli EP100 pOriF pCdiI. C) E. coli EP100 pCdiBAI pACYC184. D) E. coli EP100 pCdiBAI pCdiI.

Plasmid pCdiBAI becomes fixed in populations after long-term passage

Plasmid pCdiBAI is maintained in about half the cell population over 100 generations. Strikingly, the percentage of cells carrying pCdiBAI increased upon further passage, with carriage approaching 100% in three independent lineages after 300 generations (Fig 5A). These results suggest that mutations in host cells or the plasmid allow the episome to be fixed in the population. Mutations in repE (copA), which encodes the F replication-initiator protein, are known to increase copy number per cell and represent a possible mechanism to increase plasmid stability [39, 40]. To explore this possibility, we used Southern blotting to estimate plasmid copy number relative to a chromosomal marker. Because the parental pCdiBAI plasmid (pCdiBAIg0) is carried by only half the cells in a population, we isolated DNA from ampicillin-supplemented cultures to ensure that all cells carry plasmid. Hybridization with probes to F-plasmid DNA and the chromosomal groL locus revealed that the copy number of pCdiBAI plasmids from generation 500 (g500) increased two- to four-fold compared to plasmid pOriF and to the unpassaged (g0) pCdiBAI plasmid (Fig 5B). We also isolated pCdiBAI plasmids from each lineage after 100, 200 and 300 generations, then introduced the plasmids into bamAECL cells to assess stability in the absence of CDI selective pressure. Each "evolved" pCdiBAI plasmid was retained by a significant proportion of bamAECL cells after passage for 100 generations (Fig 5C). By contrast, the unpassaged pCdiBAIg0 plasmid was lost from the population within 50–60 generations (Fig 5C). These data indicate that the evolved plasmids are stabilized independent of CDI surveillance. We propose that prolonged passage allows the acquisition of mutations that increase copy number and fix the plasmid in the population.

Fig 5. Plasmid pCdiBAI becomes fixed in populations after long-term passage.

Fig 5

A) Three E. coli EPI100 pCdiBAI lineages were passaged for 500 cell generations, and the percentage of cells that carry plasmid pCdiBAI determined. B) Total DNA was isolated from the lineages shown in panel A after 500 generations (g500). DNA samples were digested with PstI and analyzed by Southern blot using radiolabeled probes specific for plasmid pCdiBAI and the groL chromosomal locus. Control samples isolated from cells lacking plasmid (F-), cells carrying pOriF and unpassaged cells carrying pCdiBAI (pCdiBAIg0) were also analyzed. Molecular standards were generated by PCR of plasmid pCdiBAI and the genomic groL locus. C) Plasmid DNA was isolated from the lineages in panel A after 0 (g0), 100 (g100), 200 (g200) and 300 (g300) generations. The plasmids were transformed into E. coli ΔbamA::cat pZS21-BamAECL and the percentage of cells carrying plasmid pCdiBAI was monitored over 100 generations.

DNA stabilization by colicin/immunity protein systems

Many E. coli isolates carry colicinogenic (Col) plasmids, which encode toxin/immunity systems that share some general features with CDI. Col+ strains release colicins, which are diffusible cytotoxic proteins that kill other E. coli strains. Colicins bind to specific receptors on E. coli and subsequently translocate their C-terminal toxin domains into the cell [41]. Col plasmids also encode specific immunity proteins that protect against colicin toxicity. These parallels with CDI suggest that colicin/immunity gene pairs should also stabilize genetic elements. To test this prediction, we placed the coding sequences for colicin E5 and its cognate ImE5 immunity protein onto pOriF to generate plasmid pColE5. We compared the stabilities of plasmids pOriF and pColE5 in recA+ cells (E. coli MG1655) since colicin expression is dependent on the SOS response to DNA damage and this pathway is defective in recA mutants. Plasmid pOriF was somewhat more stable in recA+ cells compared to recA- cells, but the frequency of cells carrying pOriF still declined rapidly over 100 generations (compare Figs 2A and 6A). Notably, plasmid pColE5 showed increased stability compared to pOriF (Fig 6B), but was not stabilized to the same extent as plasmid pCdiBAI (Fig 6C). These data suggest that pColE5 provides a competitive advantage to cells, presumably because it encodes immunity protein to protect against colicin intoxication. We tested this hypothesis in competition co-cultures that were seeded with a 1:1 ratio of plasmid-free rifampicin-resistant (RifR) cells with rifampicin-sensitive (RifS) cells that harbor plasmid pColE5. After incubation for 24 h, we enumerated colony forming units for each population and found that RifS descendants of the pColE5 carrying population were 8.5 fold more numerous than RifR bacteria (Fig 6D). This competitive index is significantly greater than that of cells that carry pOriF, but not as great as the advantage provided by plasmid pCdiBAI (Fig 6D). Together, these results indicate that selective pressure to retain CDI and colicin immunity helps to stabilize genetic elements in a population.

Fig 6. Colicin/immunity genes stabilize genetic elements.

Fig 6

E. coli populations harboring mini-F plasmid derivatives were passaged daily in broth culture for 100 generations. Randomly selected colonies were screened for AmpR after each passage to determine the percentage of cells that retain the plasmid. The average percentage of AmpR colonies is plotted with the standard error indicated by grey shading. A) E. coli MG1655 pOriF. B) E. coli MG1655 pColE5. C) E. coli MG1655 pCdiBAI. D) Plasmid pColE5 provides a competitive advantage. E. coli MG1655 harboring the indicated mini-F derivatives were co-cultured at a 1:1 ratio with plasmid-free, RifR MG1655 cells. The competitive index was calculated as described in Methods. The average ± standard error is presented for three independent experiments.

CDI systems are functional after horizontal transfer

Purified two-partner secretion proteins are autonomous systems and have been shown to assemble and function properly in artificial membranes [42]. These findings, together with the observation that cdi genes are typically found on mobile genetic elements, suggest that CdiB/CdiA should function in many different Gram-negative species. To test this prediction, we asked whether the cdiBAI gene cluster from E. coli EC93 is functional when expressed in Citrobacter freundii ATCC 8090. We introduced plasmid pDAL660Δ1–39, which constitutively expresses cdiBAIEC93 [13], into C. freundii and asked whether the resulting cells deploy the CDI system. C. freundii cells carrying pDAL660Δ1–39 had a significant competitive growth advantage over E. coli target cells in competition co-culture (Fig 7A). This advantage was not observed with C. freundii cells that harbor plasmid pDAL878 (Fig 7A), which is a derivative of pDAL660Δ1–39 lacking the cdiA-CT/cdiI toxin/immunity coding sequences [28]. Moreover, E. coli targets were protected from inhibition when they express the cdiI immunity gene (Fig 7A). These data demonstrate that the CDIEC93 system is functional immediately after horizontal transfer into a different species.

Fig 7. The cdiBAIEC93 genes are functional after horizontal transfer.

Fig 7

A). C. freundii cells harboring pDAL878-cat (CDI) or pDAL660Δ1-39-cat (CDI+) were co-cultured with E. coli MG1655 target cells that carry pTrc99A (vector, AmpR) or pTrc99A::cdiIEC93 (pCdiI, AmpR). Competitive indices were calculated as the ratio of C. freundii to E. coli cells at 4 h divided by the initial ratio. The average ± standard error is presented for three independent experiments. B to D). C. freundii cells harboring pDAL660Δ1-39-cat (CDI+) or pDAL878-cat (CDI) were passaged daily in broth culture for 50 generations. The cells also contained plasmids that express bamAEco or bamAECL where indicated. Randomly selected colonies were screened for Cm-resistance after each passage to determine the percentage of cells that retain the plasmid. The average percentage of CmR colonies is plotted with the standard error indicated by grey shading.

We next examined plasmid stability in the C. freundii populations. Unlike the minimal F plasmid described above, pDAL878 and pDAL660Δ1–39 carry ColE1 replication origins and are maintained as multi-copy elements in E. coli. Nevertheless, we found that pDAL878 was lost from C. freundii populations within 30 generations when released from chloramphenicol selection (Fig 7D). We have previously shown that BamA from C. freundii is not a suitable receptor for CdiAEC93 [37], suggesting that pDAL660Δ1–39 should also be lost rapidly from C. freundii populations. Therefore, we assessed pDAL660Δ1–39 stability in C. freundii cells that ectopically express either bamAEco or bamAECL from a second plasmid. As predicted, pDAL660Δ1–39 was retained in bamAEco expressing populations (Fig 7B) longer than in bamAECL populations (Fig 7C), but the element was still lost after 40 generations. These results suggest that the stabilizing effect of CDI systems is less efficient in unrelated host cells, due in part to the specificity of CdiA-receptor interactions.

Discussion

The results presented here show that CDI exerts a powerful selective pressure to retain genetic elements. The cdi genes from E. coli EC93 significantly stabilize a minimal F plasmid, allowing cells to retain this intrinsically unstable episome for more than 100 generations. However, the system has no effect in populations that lack receptors for CdiAEC93, indicating that toxin exchange between cells enforces plasmid retention. In accord with this model, a significant proportion of cells in the population show signs of CDI-mediated intoxication, suggesting that they have lost immunity because they no longer harbor the cdi plasmid. Moreover, the cdi plasmid is rapidly lost from cells that carry a second copy of the cdiI immunity gene on a separate plasmid. Collectively, these results indicate that CDI stabilizes genetic elements through a surveillance mechanism. Cells that retain the cdi plasmid remain immune, but plasmid-free cells lose immunity and are eliminated by their CDI+ siblings. This mechanism differs from the toxin-induced cell suicide strategy used by type II TA systems. Post-segregational killing relies on the rapid degradation of antitoxin to liberate cognate toxin in plasmid-free cells. Results presented here and elsewhere show that the ccdAB TA system of F is not wholly effective in killing plasmid-free daughter cells [9, 36, 43]. In principle, cells could escape post-segregational killing if the CcdA antitoxin is not degraded in a timely manner. Additionally, escape may reflect recovery from CcdB intoxication. CcdB poisons DNA gyrase and induces breaks in the genome [4446]. This activity blocks cell division and is potentially lethal. However, the lesions generated through CcdB activity also induce the SOS response, which could conceivably repair the DNA damage and promote survival. E. coli encodes an endogenous gyrase inhibitor (SbmC/GyrI) that is induced by the SOS response [47]. GyrI ameliorates the toxic effects of CcdB and has been proposed to defend against post-segregational killing [48]. Regardless of mechanism, cells that escape post-segregational killing are free to replicate with no further consequence. By contrast, individuals that lose CDI immunity are recurrently challenged by other cells in the population. This continual selection presumably provides a greater pressure to retain cdi associated genetic elements.

Community-based selection appears to be a general property of toxin/immunity competition systems. Our results show that the minimal F episome is stabilized when it expresses ColE5 toxin and its cognate ImE5 immunity protein. These results are generally consistent with previous studies showing that colicinogenic (Col+) bacteria have a competitive advantage over plasmid-free cells [4951]. This growth advantage is dependent on the initial frequency of Col+ bacteria in the population. The serial passage experiments described by Chao & Levin are most similar to our approach, and they reported Col+ bacteria rapidly dominate co-cultures when present at an initial frequency of at least 10−2 [50]. At lower initial frequencies, Col+ bacteria are outcompeted and eventually are lost from the population. The disadvantage at low initial frequencies is presumably due to slower growth rates for Col+ bacteria and the fact that Col+ cells must undergo lysis and die to release colicins into the environment. However, Col+ bacteria enjoy a much greater advantage in a structured soft-agar environment, where they dominate co-cultures from initial frequencies as low as 10−6 [50]. This latter phenomenon reflects the ability of colicins to diffuse through the medium and kill at a distance. A zone of inhibition surrounds each Col+ colony, allowing colicinogenic cells to monopolize resources within the sphere of influence. We predict that other inter-bacterial competition systems likely exert the same selective pressures. For example, bacterial type VI secretion systems have been shown to be potent inter-bacterial competition systems, capable of killing many different Gram-negative species [5254]. Like CDI systems and colicins, type VI secretion systems are encoded by mobile genetic elements [5558], and different strains of a given species typically deploy a distinct complement of toxic effector proteins [59]. Together, these observations suggest that competitive systems reflect a general strategy to reduce genetic heterogeneity. This is accomplished through growth inhibition of competing bacteria and selective inhibition of sibling segregants that have lost toxin immunity genes.

Metagenomic analyses show that cdi genes are found on genomic islands in several species including Bartonella henselae [60], Burkholderia pseudomallei [61, 62], Histophilus somni [63] and Neisseria meningitidis [64]. In addition, CDI systems are also commonly encoded on large low-copy plasmids. Cronobacter species carry a virulence plasmid that encodes predicted CDI systems [55, 65], and Shiga toxin producing O104 and O113 strains of E. coli carry their cdi genes on a plasmid [66, 67]. In fact, the E. coli EC93 cdi genes used in this study reside on a large plasmid (manuscript in preparation). Together with our findings, these observations suggest that genetic stabilization is a physiologically relevant function of cdi genes. Hacker and colleagues have isolated UPEC 536 cells lacking the PAI II536 island due to excision events, which generate non-replicating circular intermediates [3, 68]. However we found that despite PAI II536 excision in UPEC 536 strains, long-term passaging failed to yield a significant population of cells lacking the island. These results are consistent with similar studies showing that genomic islands are stable through multiple generations [29, 30]. We note that PAI II536 carries a large number of genes that may affect retention, including the yeeUV toxin-antitoxin module. Therefore, the stability of PAI II536 and other genomic islands is likely determined by the collective action of its beneficial genes, gene loss events, and selective inhibition of segregants.

E. coli cdi gene clusters show evidence of horizontal transfer at at least two levels. First, cdi genes are clearly located on large genomic islands that are integrated into the chromosome at the 3´-ends of tRNA genes. These islands are distributed sporadically across E. coli isolates and are absent from the K-12 derivatives commonly used in molecular biology laboratories. Second, the cdi genes within a given family of genomic islands often encode different toxin/immunity protein pairs, indicating that cdiA-CT/cdiI sequences can be replaced through recombination. Moreover, the regions downstream of the cdiI immunity gene vary considerably within each island family and contain fragmented cdiA-CT/cdiI gene pairs in the same transcriptional orientation as the cdiBAI cluster. We previously identified these modules as "orphan" toxin/immunity gene pairs, because they appear to be the displaced 3´-ends of cdi clusters [28]. Orphan coding regions also typically contain predicted integrase and transposase genes, suggestive of recent horizontal transfer into the island. We propose two models to explain the existence and physiological function of orphan modules. Orphan toxin/immunity genes could represent a "fossil" record of past HGT events in which ancestral cdiA-CT/cdiI sequences are preserved. In this model, newly acquired cdiA-CT/cdiI modules integrate into cdiA, thereby displacing the original toxin/immunity coding sequences downstream. Reiteration of this process could generate the tandem cdiA-CT/cdiI arrays that trail many cdi gene clusters [28]. Presumably, these orphan modules are retained for their immunity function, thereby preventing growth inhibition by neighboring parental cells. Alternatively, orphan pairs could function as a repository of “silent” toxin/immunity genes held in reserve for future deployment. Many orphan cdiA-CT fragments retain conserved sequences that are homologous to the upstream cdiA gene, and therefore homologous recombination could fuse orphan cdiA-CT/cdiI modules to cdiA. Cells undergoing such recombination would deploy a new CdiA-CT toxin, which could provide a competitive advantage under some circumstances. However, this recombination event would also delete the original cdiI immunity gene, leaving recombinants susceptible to the toxin delivered by parental cells. Alternatively, if the cdi locus was duplicated prior to homologous recombination, then a copy of the cdiI gene would remain, thereby enabling the recombinant to deploy a new toxin and retain immunity to the parental system. Chromosomal duplications are common in bacteria, and a given population will contain duplications of essentially every region of the genome [69]. Recent experiments with "evolved" Salmonella Typhimurium LT2 support the duplication-recombination model for orphan toxin utilization [70]. S. Typhimurium does not carry cdi genes, but possesses an analogous rhs (rearrangement hotspot) gene cluster that encodes a large peptide-repeat protein with a C-terminal toxin domain together with a cognate RhsI immunity protein. This locus also contains an orphan rhs-CT/rhsI module, which can recombine with the upstream rhs gene to deploy the orphan toxin. In this manner, a subpopulation of evolved cells inhibits ancestral cells with orphan toxin. Notably, reversion of this recombination can restore the ancestral rhs locus. Therefore, evolved orphan expressing cells is presumably a dynamic process in which orphan-expressing cells appear and disappear from the population. This model predicts that rhs (or cdi) recombinants do not become fixed in the population, but nevertheless these cells exert a selective pressure, perhaps explaining why orphan toxin-immunity gene pairs are retained.

HGT occurs most efficiently between closely related species [4]. For example, transfer between different haloarchaea decreases exponentially with evolutionary distance [71]. Several factors account for this bias. Some genetic competence systems preferentially take up DNA from related bacteria, and restriction endonucleases destroy DNAs that lack "self" modification patterns. Moreover, integration into the genome via homologous recombination requires relatively long tracts of sequence identity [72]. CDI surveillance should also preferentially stabilize genetic elements from closely related bacteria, because this mechanism requires recognition of specific receptors. Accordingly, the E. coli EC93 cdi genes do not stabilize plasmid in C. freundii populations, because these cells lack the appropriate CdiA receptor. Though surveillance is only possible when host cells express CdiA receptors, newly acquired cdi genes could provide other advantages. For example, CdiAEC93 contains a homotypic interaction domain that promotes BamA-independent auto-aggregation and biofilm formation [73]. Biofilms protect against a variety of environmental insults including oxidative stress, antibiotics, immune responses and predation. Unfortunately, the C. freundii cells used in this study adhere strongly to one another, making it difficult to determine whether CdiA expression affects auto-aggregation. Nevertheless, the self-adhesive properties of CdiA are potentially beneficial and could help to stabilize horizontally transferred cdi genes in the absence of surveillance.

Materials and Methods

Plasmid constructions

All mini-F plasmids are derivatives of pML31 [74]. The bla gene was amplified from pWEB-TNC using primers Amp-Hind-for (5´—TTT AAG CTT GCG GCC GCT TGA AGA CGA AAG GGC CTC G) and Amp-Eco-rev (5´—TTT GAA TTC TTG GTC TGA CAG TTA CCA ATG C). The resulting PCR product was ligated to the 8.7 kbp EcoRI/HindIII fragment of plasmid pML31 to produce pMiniF-Amp. pMiniF-Amp was digested with EcoRI and MfeI and re-ligated to remove the sopABC partitioning locus and produce plasmid pCcdAB. pCcdAB was amplified with Amp-Hind-for and OriF-Hind-rev (5´—TTT GGA TCC GCA AGC TTG GAA TAT AAA TGT CAG G) and the resulting product digested with HindIII and re-ligated to produce pOriF. The E. coli EC93 cdiBAI gene cluster was amplified using oligonucleotides cdiB-Not-for (5´—TTT GCG GCC GCA ACA CCT GAA CTG GAA CTT GTG) and cdiI-Not-rev (5´—TTT GCG GCC GCT ATT TTC TGT CTA AGA TAC TAA GGC C) and cloned into pOriF using Not I digestion to produce pCdiBAI. The col-imm-lys gene cluster was amplified from plasmid ColE5-099 using primers colE5-Not-for (5´—TTT GCG GCC GCA CCT GAT GCA GTT C) and colE5-Not-rev (5´—TTT GCG GCC GCT CAA AAC GAC AAG TTT TCT CC) and cloned into pOriF using the NotI restriction site to produce pColE5. Plasmid pDAL660Δ1–39 expresses the E. coli EC93 cdiBAI gene cluster constitutively and contains a ColE1 origin of replication [13].

Cell passage and plasmid stability

Overnight cultures of E. coli EPI100 (recA) or MG1655 (recA+) harboring mini-F plasmid derivatives were grown from frozen stocks in lysogeny broth (LB) supplemented with 100 μg/mL ampicillin (Amp). The following day, the cultures were diluted 2−10 in 2 mL fresh LB without Amp, and incubated overnight (corresponding to ~10 generations) at 37°C on roller drum. This process was repeated iteratively for three independent population lineages for ≥100 generations. At every passage, aliquots of overnight cultures were diluted and plated on LB-agar. 20 colonies were selected randomly and screened for ampicillin resistance (AmpR) on LB-agar supplemented with 100 μg/mL Amp to determine the fraction of cells carrying plasmid.

Ethidium bromide staining

E. coli harboring mini-F plasmids were grown overnight in LB medium supplemented 100 μg/mL Amp. The following day, cultures were diluted 1:100 into 2 mL of fresh LB medium without Amp and grown to OD600 ~ 1.0 at 37°C. Cells were harvested by centrifugation at 6,000 g and washed once in pre-warmed (37°C) 1 M9 salts. Cells were then resuspended in pre-warmed 1 M9 salts supplemented with 25 μM ethidium bromide (EtBr). After incubation for 2 to 5 min, cells were harvested by centrifugation and washed twice with pre-warmed 1 M9 salts. Cells were mounted on agarose pads for imaging by fluorescence microscopy. EtBr staining was scored by counting fluorescent cells and total cells (fluorescent + non-fluorescent) within images of randomly selected fields using fluorescence microscopy [19].

Southern blot analysis

Total DNA was isolated as described previously [70]. DNA (10 μg) was digested with PstI and resolved on 6% polyacrylamide gels buffered with Tris-borate-EDTA. Gel-mobility standards were generated by PCR using oligonucleotide pairs MiniF-std-for (5´—CAG TCA TGG TAC CGG CAG) and MiniF-std-rev (5´—CAG CTG GCT GAC GTA CC); and groL-std-for (5´—CAG GAC GAA CTG GAC GTG) and groL-std-rev (5´—CAG CAT AGC TTT ACG ACG ATC G). Gels were electroblotted onto nylon membrane and the blots hybridized with radiolabeled oligonucleotides MiniF-probe (5´—CAG CAG ATA TTT TGG CAG TTC A) and groL-probe (5´—GAA GTA AGG AGA CAG GTA GCC). Autoradiograms were visualized using a Bio-Rad PMI phosphorimager and Quantity One software.

Co-culture conditions

E. coli MG1655 "inhibitor" strains harboring pOriF, pCdiBAI or pColE5 were mixed at a 1:1 ratio with rifampicin-resistant (RifR) MG1655 target cells in LB media without antibiotics at a final OD600 of 0.1. Co-culture aliquots were plated onto LB-agar and LB-agar supplemented with 200 μg/mL Rif to enumerate initial cell counts as colony-forming units (CFU) per mL. Inhibitor cell counts were determined by subtracting RifR CFU from total CFU on antibiotic-free agar. Co-cultures were incubated for 24 h at 37°C with agitation, and strain counts determined by plating on non-selective and Rif-supplemented agar. For experiments in which antibiotic resistant plasmids were present (Fig 7), cells were cultured overnight in LB medium containing the appropriate antibiotic, diluted 1:100 in antibiotic free LB medium prior to competition mixing. The competitive index was calculated as the ratio of inhibitor cells to target cells at 24 h divided by the initial inhibitor to target cell ratio. Reported competitive indices represent the average ± standard error for three independent experiments.

Plasmids pDAL878-cat and pDAL660Δ1-39-cat were introduced into Citrobacter freundii ATCC 8090 cells by electroporation and transformants were selected on LB-agar supplemented with 33 μg/mL chloramphenicol (Cm). pDAL660Δ1-39-cat constitutively expresses the E. coli EC93 cdiBAI genes, and pDAL878-cat is a derivative in which the cdiA-CT/cdiI toxin/immunity sequences have been deleted [28]. C. freundii inhibitors that carry pDAL660Δ1-39-cat were co-cultured at a 10:1 ratio with E. coli MG1655 ara::spec target cells that harbor plasmid pTrc99a or pTrc99a::cdiIEC93 [38]. Initial cell counts were determined by plating the co-culture on LB-agar supplemented with 33 μg/mL Cm to enumerate C. freundii inhibitors and 50 μg/mL spectinomycin to enumerate E. coli targets. Co-cultures were incubated at 37°C with agitation for 4 h, then plated again on selective media to determine inhibitor and target cell CFU/mL. The competitive index was calculated as the ratio of inhibitor cells to target cells at 24 h divided by the initial inhibitor to target cell ratio. Reported competitive indices represent the average ± standard error for three independent experiments.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was supported by National Science Foundation grant MCB1545720 (to DAL and CSH). ZCR was supported by the Tri-Counties Blood Bank Postdoctoral Fellowship. The authors also gratefully acknowledge support from the California NanoSystems Institute (CNSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Arber W. Horizontal Gene Transfer among Bacteria and Its Role in Biological Evolution. Life (Basel). 2014;4(2):217–24. Epub 2014/11/06. doi: life4020217 [pii] 10.3390/life4020217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Darmon E, Leach DR. Bacterial genome instability. Microbiology and molecular biology reviews: MMBR. 2014;78(1):1–39. Epub 2014/03/07. doi: 78/1/1 [pii] 10.1128/MMBR.00035-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schneider G, Dobrindt U, Middendorf B, Hochhut B, Szijarto V, Emody L, et al. Mobilisation and remobilisation of a large archetypal pathogenicity island of uropathogenic Escherichia coli in vitro support the role of conjugation for horizontal transfer of genomic islands. BMC Microbiol. 2011;11:210. Epub 2011/09/29. doi: 1471-2180-11-210 [pii] 10.1186/1471-2180-11-210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Syvanen M. Evolutionary implications of horizontal gene transfer. Annual review of genetics. 2012;46:341–58. Epub 2012/09/01. 10.1146/annurev-genet-110711-155529 . [DOI] [PubMed] [Google Scholar]
  • 5.Kline BC. Aspects of plasmid F maintenance in Escherichia coli. Can J Microbiol. 1988;34(4):526–35. Epub 1988/04/01. . [DOI] [PubMed] [Google Scholar]
  • 6.Summers D. Timing, self-control and a sense of direction are the secrets of multicopy plasmid stability. Molecular microbiology. 1998;29(5):1137–45. Epub 1998/10/10. . [DOI] [PubMed] [Google Scholar]
  • 7.Hiraga S, Ogura T, Mori H, Tanaka M. Mechanisms essential for stable inheritance of mini-F plasmid. Basic Life Sci. 1985;30:469–87. Epub 1985/01/01. . [DOI] [PubMed] [Google Scholar]
  • 8.Jensen RB, Gerdes K. Programmed cell death in bacteria: proteic plasmid stabilization systems. Molecular microbiology. 1995;17(2):205–10. Epub 1995/07/01. . [DOI] [PubMed] [Google Scholar]
  • 9.Jensen RB, Grohmann E, Schwab H, Diaz-Orejas R, Gerdes K. Comparison of ccd of F, parDE of RP4, and parD of R1 using a novel conditional replication control system of plasmid R1. Molecular microbiology. 1995;17(2):211–20. Epub 1995/07/01. . [DOI] [PubMed] [Google Scholar]
  • 10.Gerdes K, Maisonneuve E. Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol. 2012;66:103–23. Epub 2012/09/22. 10.1146/annurev-micro-092611-150159 . [DOI] [PubMed] [Google Scholar]
  • 11.Goeders N, Van Melderen L. Toxin-antitoxin systems as multilevel interaction systems. Toxins (Basel). 2014;6(1):304–24. Epub 2014/01/18. doi: toxins6010304 [pii] 10.3390/toxins6010304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wozniak RA, Waldor MK. A toxin-antitoxin system promotes the maintenance of an integrative conjugative element. PLoS Genet. 2009;5(3):e1000439 Epub 2009/03/28. 10.1371/journal.pgen.1000439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Aoki SK, Pamma R, Hernday AD, Bickham JE, Braaten BA, Low DA. Contact-dependent inhibition of growth in Escherichia coli. Science. 2005;309(5738):1245–8. Epub 2005/08/20. 10.1126/science.1115109 . [DOI] [PubMed] [Google Scholar]
  • 14.Aoki SK, Diner EJ, de Roodenbeke CT, Burgess BR, Poole SJ, Braaten BA, et al. A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria. Nature. 2010;468(7322):439–42. Epub 2010/11/19. 10.1038/nature09490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hayes CS, Aoki SK, Low DA. Bacterial contact-dependent delivery systems. Annual review of genetics. 2010;44:71–90. Epub 2010/11/05. doi: 10.1146/annurev.genet.42.110807.091449 . [DOI] [PubMed] [Google Scholar]
  • 16.Beck CM, Morse RP, Cunningham DA, Iniguez A, Low DA, Goulding CW, et al. CdiA from Enterobacter cloacae delivers a toxic ribosomal RNase into target bacteria. Structure. 2014;22(5):707–18. Epub 2014/03/25. doi: S0969-2126(14)00052-5 [pii] 10.1016/j.str.2014.02.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Willett JL, Ruhe ZC, Goulding CW, Low DA, Hayes CS. Contact-Dependent Growth Inhibition (CDI) and CdiB/CdiA Two-Partner Secretion Proteins. J Mol Biol. 2015;427(23):3754–65. Epub 2015/09/22. doi: S0022-2836(15)00521-5 [pii] 10.1016/j.jmb.2015.09.010 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Aoki SK, Malinverni JC, Jacoby K, Thomas B, Pamma R, Trinh BN, et al. Contact-dependent growth inhibition requires the essential outer membrane protein BamA (YaeT) as the receptor and the inner membrane transport protein AcrB. Molecular microbiology. 2008;70(2):323–40. Epub 2008/09/03. 10.1111/j.1365-2958.2008.06404.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Webb JS, Nikolakakis KC, Willett JL, Aoki SK, Hayes CS, Low DA. Delivery of CdiA nuclease toxins into target cells during contact-dependent growth inhibition. PLoS ONE. 2013;8(2):e57609 10.1371/journal.pone.0057609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Willett JL, Gucinski GC, Fatherree JP, Low DA, Hayes CS. Contact-dependent growth inhibition toxins exploit multiple independent cell-entry pathways. Proc Natl Acad Sci U S A. 2015;112(36):11341–6. Epub 2015/08/26. doi: 1512124112 [pii] 10.1073/pnas.1512124112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Nikolakakis K, Amber S, Wilbur JS, Diner EJ, Aoki SK, Poole SJ, et al. The toxin/immunity network of Burkholderia pseudomallei contact-dependent growth inhibition (CDI) systems. Molecular microbiology. 2012;84(3):516–29. Epub 2012/03/23. 10.1111/j.1365-2958.2012.08039.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ruhe ZC, Low DA, Hayes CS. Bacterial contact-dependent growth inhibition. Trends Microbiol. 2013;21(5):230–7. Epub 2013/03/12. doi: S0966-842X(13)00023-1 [pii] 10.1016/j.tim.2013.02.003 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Aoki SK, Webb JS, Braaten BA, Low DA. Contact-dependent growth inhibition causes reversible metabolic downregulation in Escherichia coli. Journal of bacteriology. 2009;191(6):1777–86. Epub 2009/01/07. 10.1128/JB.01437-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Seitzer P, Huynh TA, Facciotti MT. JContextExplorer: a tree-based approach to facilitate cross-species genomic context comparison. BMC Bioinformatics. 2013;14:18 10.1186/1471-2105-14-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dobrindt U, Blum-Oehler G, Nagy G, Schneider G, Johann A, Gottschalk G, et al. Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536. Infect Immun. 2002;70(11):6365–72. Epub 2002/10/16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Diner EJ, Beck CM, Webb JS, Low DA, Hayes CS. Identification of a target cell permissive factor required for contact-dependent growth inhibition (CDI). Genes Dev. 2012;26(5):515–25. Epub 2012/02/16. doi: gad.182345.111 [pii] 10.1101/gad.182345.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang D, de Souza RF, Anantharaman V, Iyer LM, Aravind L. Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics. Biol Direct. 2012;7:18. Epub 2012/06/27. doi: 1745-6150-7-18 [pii] 10.1186/1745-6150-7-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Poole SJ, Diner EJ, Aoki SK, Braaten BA, t'Kint de Roodenbeke C, Low DA, et al. Identification of functional toxin/immunity genes linked to contact-dependent growth inhibition (CDI) and rearrangement hotspot (Rhs) systems. PLoS Genet. 2011;7(8):e1002217 Epub 2011/08/11. 10.1371/journal.pgen.1002217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kiss J, Nagy B, Olasz F. Stability, entrapment and variant formation of Salmonella genomic island 1. PLoS One. 2012;7(2):e32497 10.1371/journal.pone.0032497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Quesada JM, Soriano MI, Espinosa-Urgel M. Stability of a Pseudomonas putida KT2440 bacteriophage-carried genomic island and its impact on rhizosphere fitness. Appl Environ Microbiol. 2012;78(19):6963–74. 10.1128/AEM.00901-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cottell JL, Saw HT, Webber MA, Piddock LJ. Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid. BMC Microbiol. 2014;14:168. Epub 2014/06/26. doi: 1471-2180-14-168 [pii] 10.1186/1471-2180-14-168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lau BT, Malkus P, Paulsson J. New quantitative methods for measuring plasmid loss rates reveal unexpected stability. Plasmid. 2013;70(3):353–61. 10.1016/j.plasmid.2013.07.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Eichenlaub R, Figurski D, Helinski DR. Bidirection replication from a unique origin in a mini-F plasmid. Proc Natl Acad Sci U S A. 1977;74(3):1138–41. Epub 1977/03/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gerdes K, Moller-Jensen J, Ebersbach G, Kruse T, Nordstrom K. Bacterial mitotic machineries. Cell. 2004;116(3):359–66. Epub 2004/03/16. doi: S0092867404001163 [pii]. . [DOI] [PubMed] [Google Scholar]
  • 35.Jaffe A, Ogura T, Hiraga S. Effects of the ccd function of the F plasmid on bacterial growth. Journal of bacteriology. 1985;163(3):841–9. Epub 1985/09/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ogura T, Hiraga S. Mini-F plasmid genes that couple host cell division to plasmid proliferation. Proc Natl Acad Sci U S A. 1983;80(15):4784–8. Epub 1983/08/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ruhe ZC, Wallace AB, Low DA, Hayes CS. Receptor polymorphism restricts contact-dependent growth inhibition to members of the same species. mBio. 2013;4(4):e00480–13. Epub 2013/07/25. doi: mBio.00480-13 [pii] 10.1128/mBio.00480-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ruhe ZC, Nguyen JY, Beck CM, Low DA, Hayes CS. The proton-motive force is required for translocation of CDI toxins across the inner membrane of target bacteria. Molecular microbiology. 2014;94(2):466–81. Epub 2014/09/02. 10.1111/mmi.12779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kline BC, Trawick J. Identification and characterization of a second copy number control gene in mini-F plasmids. Mol Gen Genet. 1983;192(3):408–15. Epub 1983/01/01. . [DOI] [PubMed] [Google Scholar]
  • 40.Kawasaki Y, Wada C, Yura T. Mini-F plasmid mutants able to replicate in the absence of sigma 32: mutations in the repE coding region producing hyperactive initiator protein. Journal of bacteriology. 1991;173(3):1064–72. Epub 1991/02/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cascales E, Buchanan SK, Duche D, Kleanthous C, Lloubes R, Postle K, et al. Colicin biology. Microbiology and molecular biology reviews: MMBR. 2007;71(1):158–229. Epub 2007/03/10. 10.1128/MMBR.00036-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Norell D, Heuck A, Tran-Thi TA, Gotzke H, Jacob-Dubuisson F, Clausen T, et al. Versatile in vitro system to study translocation and functional integration of bacterial outer membrane proteins. Nat Commun. 2014;5:5396. Epub 2014/11/06. doi: ncomms6396 [pii] 10.1038/ncomms6396 . [DOI] [PubMed] [Google Scholar]
  • 43.Boe L, Gerdes K, Molin S. Effects of genes exerting growth inhibition and plasmid stability on plasmid maintenance. Journal of bacteriology. 1987;169(10):4646–50. Epub 1987/10/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bernard P, Couturier M. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol. 1992;226(3):735–45. Epub 1992/08/05. doi: 0022-2836(92)90629-X [pii]. . [DOI] [PubMed] [Google Scholar]
  • 45.Bernard P, Kezdy KE, Van Melderen L, Steyaert J, Wyns L, Pato ML, et al. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J Mol Biol. 1993;234(3):534–41. Epub 1993/12/05. doi: S0022-2836(83)71609-8 [pii] 10.1006/jmbi.1993.1609 . [DOI] [PubMed] [Google Scholar]
  • 46.Couturier M, Bahassi el M, Van Melderen L. Bacterial death by DNA gyrase poisoning. Trends Microbiol. 1998;6(7):269–75. Epub 1998/08/26. doi: S0966842X98013110 [pii]. . [DOI] [PubMed] [Google Scholar]
  • 47.Baquero MR, Bouzon M, Varea J, Moreno F. sbmC, a stationary-phase induced SOS Escherichia coli gene, whose product protects cells from the DNA replication inhibitor microcin B17. Molecular microbiology. 1995;18(2):301–11. Epub 1995/10/01. . [DOI] [PubMed] [Google Scholar]
  • 48.Nakanishi A, Oshida T, Matsushita T, Imajoh-Ohmi S, Ohnuki T . Identification of DNA gyrase inhibitor (GyrI) in Escherichia coli. J Biol Chem. 1998;273(4):1933–8. Epub 1998/01/27. . [DOI] [PubMed] [Google Scholar]
  • 49.Adams J, Kinney T, Thompson S, Rubin L, Helling RB. Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics. 1979;91(4):627–37. Epub 1979/04/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Chao L, Levin BR. Structured habitats and the evolution of anticompetitor toxins in bacteria. Proc Natl Acad Sci U S A. 1981;78(10):6324–8. Epub 1981/10/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Lauffenburger DA. Stability of colicin plasmids in continuous culture: mathematical model and analysis. Biotechnol Prog. 1985;1(1):53–9. Epub 1985/03/01. 10.1002/btpr.5420010111 . [DOI] [PubMed] [Google Scholar]
  • 52.Hood RD, Singh P, Hsu F, Guvener T, Carl MA, Trinidad RR, et al. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe. 2010;7(1):25–37. Epub 2010/02/02. doi: S1931-3128(09)00417-X [pii] 10.1016/j.chom.2009.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S. The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci U S A. 2010;107(45):19520–4. Epub 2010/10/27. doi: 1012931107 [pii] 10.1073/pnas.1012931107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Russell AB, Peterson SB, Mougous JD. Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol. 2014;12(2):137–48. Epub 2014/01/05. doi: nrmicro3185 [pii] 10.1038/nrmicro3185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Franco AA, Hu L, Grim CJ, Gopinath G, Sathyamoorthy V, Jarvis KG, et al. Characterization of putative virulence genes on the related RepFIB plasmids harbored by Cronobacter spp. Appl Environ Microbiol. 2011;77(10):3255–67. Epub 2011/03/23. doi: AEM.03023-10 [pii] 10.1128/AEM.03023-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Broms JE, Meyer L, Lavander M, Larsson P, Sjostedt A. DotU and VgrG, core components of type VI secretion systems, are essential for Francisella LVS pathogenicity. PLoS One. 2012;7(4):e34639 Epub 2012/04/20. 10.1371/journal.pone.0034639 PONE-D-12-02842 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Brunet YR, Khodr A, Logger L, Aussel L, Mignot T, Rimsky S, et al. H-NS Silencing of the Salmonella Pathogenicity Island 6-Encoded Type VI Secretion System Limits Salmonella enterica Serovar Typhimurium Interbacterial Killing. Infect Immun. 2015;83(7):2738–50. Epub 2015/04/29. doi: IAI.00198-15 [pii] 10.1128/IAI.00198-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Bartonickova L, Sterzenbach T, Nell S, Kops F, Schulze J, Venzke A, et al. Hcp and VgrG1 are secreted components of the Helicobacter hepaticus type VI secretion system and VgrG1 increases the bacterial colitogenic potential. Cell Microbiol. 2013;15(6):992–1011. Epub 2013/01/03. 10.1111/cmi.12094 . [DOI] [PubMed] [Google Scholar]
  • 59.Unterweger D, Miyata ST, Bachmann V, Brooks TM, Mullins T, Kostiuk B, et al. The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition. Nat Commun. 2014;5:3549. Epub 2014/04/02. doi: ncomms4549 [pii] 10.1038/ncomms4549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Alsmark CM, Frank AC, Karlberg EO, Legault BA, Ardell DH, Canback B, et al. The louse-borne human pathogen Bartonella quintana is a genomic derivative of the zoonotic agent Bartonella henselae. Proc Natl Acad Sci U S A. 2004;101(26):9716–21. Epub 2004/06/24. 10.1073/pnas.0305659101 0305659101 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Mayo M, et al. Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics. 2008;9:566. Epub 2008/11/29. doi: 1471-2164-9-566 [pii] 10.1186/1471-2164-9-566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Tumapa S, Holden MT, Vesaratchavest M, Wuthiekanun V, Limmathurotsakul D, Chierakul W, et al. Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics. 2008;9:190. Epub 2008/04/29. doi: 1471-2164-9-190 [pii] 10.1186/1471-2164-9-190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Siddaramappa S, Challacombe JF, Duncan AJ, Gillaspy AF, Carson M, Gipson J, et al. Horizontal gene transfer in Histophilus somni and its role in the evolution of pathogenic strain 2336, as determined by comparative genomic analyses. BMC Genomics. 2011;12:570. Epub 2011/11/25. doi: 1471-2164-12-570 [pii] 10.1186/1471-2164-12-570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Klee SR, Nassif X, Kusecek B, Merker P, Beretti JL, Achtman M, et al. Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae. Infect Immun. 2000;68(4):2082–95. Epub 2000/03/18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Yan Q, Power KA, Cooney S, Fox E, Gopinath GR, Grim CJ, et al. Complete genome sequence and phenotype microarray analysis of Cronobacter sakazakii SP291: a persistent isolate cultured from a powdered infant formula production facility. Front Microbiol. 2013;4:256 Epub 2013/09/14. 10.3389/fmicb.2013.00256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Newton HJ, Sloan J, Bulach DM, Seemann T, Allison CC, Tauschek M, et al. Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg Infect Dis. 2009;15(3):372–80. Epub 2009/02/26. 10.3201/eid1503.080631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Yan X, Fratamico PM, Bono JL, Baranzoni GM, Chen CY. Genome sequencing and comparative genomics provides insights on the evolutionary dynamics and pathogenic potential of different H-serotypes of Shiga toxin-producing Escherichia coli O104. BMC Microbiol. 2015;15:83 Epub 2015/04/19. 10.1186/s12866-015-0413-9 10.1186/s12866-015-0413-9 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Middendorf B, Hochhut B, Leipold K, Dobrindt U, Blum-Oehler G, Hacker J. Instability of pathogenicity islands in uropathogenic Escherichia coli 536. Journal of bacteriology. 2004;186(10):3086–96. Epub 2004/05/06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Reams AB, Kofoid E, Savageau M, Roth JR. Duplication frequency in a population of Salmonella enterica rapidly approaches steady state with or without recombination. Genetics. 2010;184(4):1077–94. Epub 2010/01/20. doi: genetics.109.111963 [pii] 10.1534/genetics.109.111963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Koskiniemi S, Garza-Sanchez F, Sandegren L, Webb JS, Braaten BA, Poole SJ, et al. Selection of orphan Rhs toxin expression in evolved Salmonella enterica serovar Typhimurium. PLoS Genet. 2014;10(3):e1004255 Epub 2014/03/29. 10.1371/journal.pgen.1004255 PGENETICS-D-13-02715 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Williams D, Gogarten JP, Papke RT. Quantifying homologous replacement of loci between haloarchaeal species. Genome Biol Evol. 2012;4(12):1223–44. Epub 2012/11/20. doi: evs098 [pii] 10.1093/gbe/evs098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Mell JC, Redfield RJ. Natural competence and the evolution of DNA uptake specificity. Journal of bacteriology. 2014;196(8):1471–83. Epub 2014/02/04. doi: JB.01293-13 [pii] 10.1128/JB.01293-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Ruhe ZC, Townsley L, Wallace AB, King A, Van der Woude MW, Low DA, et al. CdiA promotes receptor-independent intercellular adhesion. Molecular microbiology. 2015:in press. Epub 2015/07/03. 10.1111/mmi.13114 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Lovett MA, Helinski DR. Method for the isolation of the replication region of a bacterial replicon: construction of a mini-F'kn plasmid. Journal of bacteriology. 1976;127(2):982–7. Epub 1976/08/01. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.


Articles from PLoS Genetics are provided here courtesy of PLOS

RESOURCES